Aims at developing new families of molecules to be used for in vivo dna surgery, as a therapeutic approach to genetic and viral diseases, or to be used as industrial tools.
In previous projects, efficient micropropagation, regeneration and transformation procedures have been developed. In this project we intend to commercially micropropagate elite apricot cultivars and regenerate transformed apricot plantlets
Combining molecular technologies which permit identification - quantification of micro-organisms without cultivation and a decision diagram suggested by hygienists, whereby emerging nosocomial pathogens could be more rapidly detected and eradicated from the health area.
To select efficient symbiotic soil fungi for production of blueberries,raspberries&mulberries in arid ecosystems.The outcome will be novel mycorrhizal inocula tuned to increase stress tolerance of plants&reduce the input of agrochemicals.
Development of different dosage forms containing doxycycline alone or associated with paracetamol or others, for improving the extrinsic and intrinsic characteristics for a safe and rationale use of this antibiotic in animal health.
Development and validation of a prediction algorithm for rationalisation of the dosing strategies for higher risk drugs
In a concerted effort, dnage, biobide and academia will set up a novel drug development tool. A new method for rapid identification of new therapeutics in the field of osteoporosis and other ageing related diseases will be developed.
Development and validation of a blood group genotyping system based on dna microarray technology that could be applied to high throughput donor typing.
Iron deficiency is the main cause of nutritional anaemias and is a world health problem. The objective is to obtain heme iron from animal haemoglobin in suitable administration form in order to conduct absorption studies with a target population.
The project develops a new system for the automated staining of blood, bone marrow & sputum slides for haematology, bacteriology & mycobacteriology. It will be designed to answer the needs of small clinical laboratories, notably in low resource countries & in regions stricken by tuberculosis.